Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic of the Antihypertensive Response to the Angiotensin II Blockers in Monotherapy or Associated to Hydrochlorothiazide

NCT00617877 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT00617877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic of the Antihypertensive Response to the Angiotensin II Blockers in Monotherapy or Associated to Hydrochlorothiazide
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
June 30, 2009
Enrollment
800 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension